Rare Disease Lead Generation
TrialCard’s Lead Generation product is well suited to the growing orphan drug market. Specialty representatives, trained on the science of a particular therapy, use talking points and probing questions in calls with target offices to uncover potential patients that may benefit from orphan therapies.
The impact of a TrialCard program, on a scale of 1 to 10.
*Info from a recent client survey
Rare disease Virtual Specialty Representatives program (2 FTE 6-Month Model)
Delivered 10 times more leads than forecasted
Virtual Specialty Representatives gained access through appointments with “no-see” healthcare professionals
- Directly connected 15 patients to therapy
Problem-solving makes our day.
Contact us for answers.